MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

centene_logo_white-svg

CENTENE CORP (CNC)

centene_logo_white-svg

CENTENE CORP (CNC)

|||

Cash Flow Overview

Change in Cash
$3,392M
Free Cash flow
$4,166M
Unit: Million (M) dollars
Positive Cash Flow Breakdown
    • Accounts payable and accrued exp...
    • Net earnings
    • Sales and maturities of investme...
    • Others
Negative Cash Flow Breakdown
    • Premium and trade receivables
    • Payments and repurchases of long...
    • Purchases of investments
    • Others

Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net earnings
1,539 -1,100 -6,632 -259
Depreciation and amortization
300 329 317 315
Stock compensation expense
67 58 52 35
Impairment
NaN 513 6,743 55
Loss on debt extinguishment
-5 1 NaN NaN
Deferred income taxes
-53 -73 129 -89
Loss on divestitures
0 12 0 0
Other adjustments, net
NaN NaN NaN -11
Premium and trade receivables
1,353 -4,818 1,537 -883
Other assets
188 -15 -298 -126
Medical claims liabilities
95 -840 1,367 206
Unearned revenue
217 85 -26 -187
Accounts payable and accrued expenses
2,905 -3,338 2,472 -354
Other long-term liabilities
849 -84 -1,819 1,043
Other operating activities, net
-17 67 8 0
Net cash provided by operating activities
4,366 437 1,356 1,785
Capital expenditures
200 213 211 208
Purchases of investments
987 776 172 1,963
Sales and maturities of investments
1,276 1,649 1,623 1,272
Divestiture proceeds, net of divested cash
NaN 0 0 0
Net cash provided by (used in) investing activities
89 660 1,240 -899
Proceeds from long-term debt
0 0 0 0
Payments and repurchases of long-term debt
1,046 187 1 749
Common stock repurchases
29 2 0 432
Proceeds from common stock issuances
10 8 11 8
Purchase of noncontrolling interest
NaN 0 19 NaN
Other financing activities, net
2 -6 -1 -1
Net cash (used in) financing activities
-1,063 -187 -10 -1,174
Effect of exchange rate changes on cash, cash equivalents and restricted cash
NaN 0 0 0
Net increase in cash, cash equivalents and restricted cash and cash equivalents
3,392 910 2,586 -288
Cash and cash equivalents reclassified from held for sale
4 NaN NaN NaN
Cash, cash equivalents and restricted cash and cash equivalents, beginning of period
17,185 NaN 14,599 14,887
Cash, cash equivalents and restricted cash and cash equivalents, end of period
21,353 NaN 17,185 14,599
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Accounts payable andaccrued expenses$2,905M (415.99%↑ Y/Y)Net earnings$1,539M (17.12%↑ Y/Y)Sales and maturitiesof investments$1,276M (3.24%↑ Y/Y)Other long-termliabilities$849M (4.30%↑ Y/Y)Depreciation andamortization$300M (-4.46%↓ Y/Y)Unearned revenue$217M (4.33%↑ Y/Y)Medical claimsliabilities$95M (-94.07%↓ Y/Y)Stock compensationexpense$67M (13.56%↑ Y/Y)Loss on debtextinguishment-$5M Net cash provided byoperating activities$4,366M (189.14%↑ Y/Y)Net cash provided by(used in) investing...$89M (116.82%↑ Y/Y)Canceled cashflow$1,611M Canceled cashflow$1,187M Net increase incash, cash...$3,392M (364.02%↑ Y/Y)Canceled cashflow$1,063M Premium and tradereceivables$1,353M (-49.59%↓ Y/Y)Other assets$188M (-71.90%↓ Y/Y)Deferred income taxes-$53M (-96.30%↓ Y/Y)Other operatingactivities, net-$17M Proceeds from commonstock issuances$10M (0.00%↑ Y/Y)Other financingactivities, net$2M (118.18%↑ Y/Y)Purchases of investments$987M (-39.45%↓ Y/Y)Capital expenditures$200M (48.15%↑ Y/Y)Net cash (used in)financing activities-$1,063M (-325.20%↓ Y/Y)Canceled cashflow$12M Payments and repurchasesof long-term debt$1,046M (9.19%↑ Y/Y)Common stockrepurchases$29M (-29.27%↓ Y/Y)